Global Codeine

Codeine Comprehensive Study by Type (Extracted from Opium, Synthesized by Morphine), Application (Pain Management, Cough Treatment, Diarrhea Treatment), Forms (Tablets, Capsules, Suppositories, Soluble Powders and Tablets, Liquids), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others) Players and Region - Global Market Outlook to 2026

Codeine Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
The global Codeine market is expected to witness high demand in the forecasted period due to the alarming increase in the incidence of orthopedic diseases & chronic pain. Codeine is part of a group of drugs known as opioids. Opioids interact with opioid receptors in the brain and elicit a range of responses within the body, from feelings of pain relief to relaxation, pleasure, and contentment. Codeine is used to provide relief from a number of conditions, including mild to moderate pain, severe pain, dry irritating cough, diarrhea, and cold and flu. In Australia, Canada, New Zealand, Sweden, the United Kingdom, the United States, and many other countries, codeine is regulated under various narcotic control laws.

AttributesDetails
Study Period2017-2027
Base Year2021
High Growth MarketAsia Pacific
UnitValue (USD Million)
Key Companies ProfiledPurdue Pharma (United States), Sanofi (France), Pfizer (United States), Janssen Pharmaceuticals (Belgium), Endo Pharmaceuticals, Inc (United States), Actavis Plc (United States), Egalet (United States), Sun Pharmaceuticals (India) and Boehringer Ingelheim GmbH (Germany)


This growth is primarily driven by The Rise in Disposable Income and Surge in Global Geriatric Population and Increasing Investment in Healthcare Sectors.

Globally, a noticeable market trend is evident The Increasing Focus on the Abuse-Deterrent Formulation (ADF) The Pharmaceuticals sector in the North America region has been increasing at a sustainable rate, and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Purdue Pharma (United States), Sanofi (France), Pfizer (United States), Janssen Pharmaceuticals (Belgium), Endo Pharmaceuticals, Inc (United States), Actavis Plc (United States), Egalet (United States), Sun Pharmaceuticals (India) and Boehringer Ingelheim GmbH (Germany), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years. The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to avail a competitive advantage through combined collaborations.

Regulatory Insights:
"In Canada, the use of opioids, including codeine, is currently regulated by the Controlled Drugs and Substances Act. Due to the potential of developing dependence among users, most codeine products are available by prescription only. Low-dose codeine (doses lower than or equal to 30 mg per tablet or 2 mg per milliliter [mL]), however, can be sold without a prescription if used in combination with at least two other medications. These are available as ‘over the counter’ (OTC) medications but are usually stored behind the pharmacy counter. In Manitoba, low-dose codeine products are available only by prescription."

Influencing Trend:
The Increasing Focus on the Abuse-Deterrent Formulation (ADF) and The Growing Prevalence of Orthopedic Diseases and Chronic Pain

Market Growth Drivers:
The Rise in Disposable Income and Surge in Global Geriatric Population and Increasing Investment in Healthcare Sectors

Challenges:
The Stringent Government Regulation Associated with Codeine

Restraints:
The Growing Concern Related to the Legalization of Cannabis and Increasing Issues Related to Prescription Drug Abuse

Opportunities:
The Increase in Consumption of Opioid Analgesic for Pain Management in Developing Countries and Rising Demand due to Ongoing Research and Developments in the Treatment Area

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints in Codeine Market
- Analysis about New Entrants in Codeine Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
- An Unbiased Perspective towards Market Performance & Indicators

Against this Challenging Backdrop, Codeine Study Sheds Light on
— The Codeine Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Codeine industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Codeine industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Extracted from Opium
  • Synthesized by Morphine
By Application
  • Pain Management
  • Cough Treatment
  • Diarrhea Treatment
By Forms
  • Tablets
  • Capsules
  • Suppositories
  • Soluble Powders and Tablets
  • Liquids

By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Rise in Disposable Income and Surge in Global Geriatric Population
      • 3.2.2. Increasing Investment in Healthcare Sectors
    • 3.3. Market Challenges
      • 3.3.1. The Stringent Government Regulation Associated with Codeine
    • 3.4. Market Trends
      • 3.4.1. The Increasing Focus on the Abuse-Deterrent Formulation (ADF)
      • 3.4.2. The Growing Prevalence of Orthopedic Diseases and Chronic Pain
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Codeine, by Type, Application, Forms, Distribution Channel and Region (value, volume and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Codeine (Value)
      • 5.2.1. Global Codeine by: Type (Value)
        • 5.2.1.1. Extracted from Opium
        • 5.2.1.2. Synthesized by Morphine
      • 5.2.2. Global Codeine by: Application (Value)
        • 5.2.2.1. Pain Management
        • 5.2.2.2. Cough Treatment
        • 5.2.2.3. Diarrhea Treatment
      • 5.2.3. Global Codeine by: Forms (Value)
        • 5.2.3.1. Tablets
        • 5.2.3.2. Capsules
        • 5.2.3.3. Suppositories
        • 5.2.3.4. Soluble Powders and Tablets
        • 5.2.3.5. Liquids
      • 5.2.4. Global Codeine by: Distribution Channel (Value)
        • 5.2.4.1. Hospital Pharmacies
        • 5.2.4.2. Retail Pharmacies
        • 5.2.4.3. Others
      • 5.2.5. Global Codeine Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Codeine (Volume)
      • 5.3.1. Global Codeine by: Type (Volume)
        • 5.3.1.1. Extracted from Opium
        • 5.3.1.2. Synthesized by Morphine
      • 5.3.2. Global Codeine by: Application (Volume)
        • 5.3.2.1. Pain Management
        • 5.3.2.2. Cough Treatment
        • 5.3.2.3. Diarrhea Treatment
      • 5.3.3. Global Codeine by: Forms (Volume)
        • 5.3.3.1. Tablets
        • 5.3.3.2. Capsules
        • 5.3.3.3. Suppositories
        • 5.3.3.4. Soluble Powders and Tablets
        • 5.3.3.5. Liquids
      • 5.3.4. Global Codeine by: Distribution Channel (Volume)
        • 5.3.4.1. Hospital Pharmacies
        • 5.3.4.2. Retail Pharmacies
        • 5.3.4.3. Others
      • 5.3.5. Global Codeine Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Codeine (Price)
      • 5.4.1. Global Codeine by: Type (Price)
  • 6. Codeine: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Purdue Pharma (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Sanofi (France)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Pfizer (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Janssen Pharmaceuticals (Belgium)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Endo Pharmaceuticals, Inc (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Actavis Plc (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Egalet (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Sun Pharmaceuticals (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Boehringer Ingelheim GmbH (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Codeine Sale, by Type, Application, Forms, Distribution Channel and Region (value, volume and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Codeine (Value)
      • 7.2.1. Global Codeine by: Type (Value)
        • 7.2.1.1. Extracted from Opium
        • 7.2.1.2. Synthesized by Morphine
      • 7.2.2. Global Codeine by: Application (Value)
        • 7.2.2.1. Pain Management
        • 7.2.2.2. Cough Treatment
        • 7.2.2.3. Diarrhea Treatment
      • 7.2.3. Global Codeine by: Forms (Value)
        • 7.2.3.1. Tablets
        • 7.2.3.2. Capsules
        • 7.2.3.3. Suppositories
        • 7.2.3.4. Soluble Powders and Tablets
        • 7.2.3.5. Liquids
      • 7.2.4. Global Codeine by: Distribution Channel (Value)
        • 7.2.4.1. Hospital Pharmacies
        • 7.2.4.2. Retail Pharmacies
        • 7.2.4.3. Others
      • 7.2.5. Global Codeine Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Codeine (Volume)
      • 7.3.1. Global Codeine by: Type (Volume)
        • 7.3.1.1. Extracted from Opium
        • 7.3.1.2. Synthesized by Morphine
      • 7.3.2. Global Codeine by: Application (Volume)
        • 7.3.2.1. Pain Management
        • 7.3.2.2. Cough Treatment
        • 7.3.2.3. Diarrhea Treatment
      • 7.3.3. Global Codeine by: Forms (Volume)
        • 7.3.3.1. Tablets
        • 7.3.3.2. Capsules
        • 7.3.3.3. Suppositories
        • 7.3.3.4. Soluble Powders and Tablets
        • 7.3.3.5. Liquids
      • 7.3.4. Global Codeine by: Distribution Channel (Volume)
        • 7.3.4.1. Hospital Pharmacies
        • 7.3.4.2. Retail Pharmacies
        • 7.3.4.3. Others
      • 7.3.5. Global Codeine Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Codeine (Price)
      • 7.4.1. Global Codeine by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Codeine: by Type(USD Million)
  • Table 2. Codeine Extracted from Opium , by Region USD Million (2016-2021)
  • Table 3. Codeine Synthesized by Morphine , by Region USD Million (2016-2021)
  • Table 4. Codeine: by Application(USD Million)
  • Table 5. Codeine Pain Management , by Region USD Million (2016-2021)
  • Table 6. Codeine Cough Treatment , by Region USD Million (2016-2021)
  • Table 7. Codeine Diarrhea Treatment , by Region USD Million (2016-2021)
  • Table 8. Codeine: by Forms(USD Million)
  • Table 9. Codeine Tablets , by Region USD Million (2016-2021)
  • Table 10. Codeine Capsules , by Region USD Million (2016-2021)
  • Table 11. Codeine Suppositories , by Region USD Million (2016-2021)
  • Table 12. Codeine Soluble Powders and Tablets , by Region USD Million (2016-2021)
  • Table 13. Codeine Liquids , by Region USD Million (2016-2021)
  • Table 14. Codeine: by Distribution Channel(USD Million)
  • Table 15. Codeine Hospital Pharmacies , by Region USD Million (2016-2021)
  • Table 16. Codeine Retail Pharmacies , by Region USD Million (2016-2021)
  • Table 17. Codeine Others , by Region USD Million (2016-2021)
  • Table 18. South America Codeine, by Country USD Million (2016-2021)
  • Table 19. South America Codeine, by Type USD Million (2016-2021)
  • Table 20. South America Codeine, by Application USD Million (2016-2021)
  • Table 21. South America Codeine, by Forms USD Million (2016-2021)
  • Table 22. South America Codeine, by Distribution Channel USD Million (2016-2021)
  • Table 23. Brazil Codeine, by Type USD Million (2016-2021)
  • Table 24. Brazil Codeine, by Application USD Million (2016-2021)
  • Table 25. Brazil Codeine, by Forms USD Million (2016-2021)
  • Table 26. Brazil Codeine, by Distribution Channel USD Million (2016-2021)
  • Table 27. Argentina Codeine, by Type USD Million (2016-2021)
  • Table 28. Argentina Codeine, by Application USD Million (2016-2021)
  • Table 29. Argentina Codeine, by Forms USD Million (2016-2021)
  • Table 30. Argentina Codeine, by Distribution Channel USD Million (2016-2021)
  • Table 31. Rest of South America Codeine, by Type USD Million (2016-2021)
  • Table 32. Rest of South America Codeine, by Application USD Million (2016-2021)
  • Table 33. Rest of South America Codeine, by Forms USD Million (2016-2021)
  • Table 34. Rest of South America Codeine, by Distribution Channel USD Million (2016-2021)
  • Table 35. Asia Pacific Codeine, by Country USD Million (2016-2021)
  • Table 36. Asia Pacific Codeine, by Type USD Million (2016-2021)
  • Table 37. Asia Pacific Codeine, by Application USD Million (2016-2021)
  • Table 38. Asia Pacific Codeine, by Forms USD Million (2016-2021)
  • Table 39. Asia Pacific Codeine, by Distribution Channel USD Million (2016-2021)
  • Table 40. China Codeine, by Type USD Million (2016-2021)
  • Table 41. China Codeine, by Application USD Million (2016-2021)
  • Table 42. China Codeine, by Forms USD Million (2016-2021)
  • Table 43. China Codeine, by Distribution Channel USD Million (2016-2021)
  • Table 44. Japan Codeine, by Type USD Million (2016-2021)
  • Table 45. Japan Codeine, by Application USD Million (2016-2021)
  • Table 46. Japan Codeine, by Forms USD Million (2016-2021)
  • Table 47. Japan Codeine, by Distribution Channel USD Million (2016-2021)
  • Table 48. India Codeine, by Type USD Million (2016-2021)
  • Table 49. India Codeine, by Application USD Million (2016-2021)
  • Table 50. India Codeine, by Forms USD Million (2016-2021)
  • Table 51. India Codeine, by Distribution Channel USD Million (2016-2021)
  • Table 52. South Korea Codeine, by Type USD Million (2016-2021)
  • Table 53. South Korea Codeine, by Application USD Million (2016-2021)
  • Table 54. South Korea Codeine, by Forms USD Million (2016-2021)
  • Table 55. South Korea Codeine, by Distribution Channel USD Million (2016-2021)
  • Table 56. Taiwan Codeine, by Type USD Million (2016-2021)
  • Table 57. Taiwan Codeine, by Application USD Million (2016-2021)
  • Table 58. Taiwan Codeine, by Forms USD Million (2016-2021)
  • Table 59. Taiwan Codeine, by Distribution Channel USD Million (2016-2021)
  • Table 60. Australia Codeine, by Type USD Million (2016-2021)
  • Table 61. Australia Codeine, by Application USD Million (2016-2021)
  • Table 62. Australia Codeine, by Forms USD Million (2016-2021)
  • Table 63. Australia Codeine, by Distribution Channel USD Million (2016-2021)
  • Table 64. Rest of Asia-Pacific Codeine, by Type USD Million (2016-2021)
  • Table 65. Rest of Asia-Pacific Codeine, by Application USD Million (2016-2021)
  • Table 66. Rest of Asia-Pacific Codeine, by Forms USD Million (2016-2021)
  • Table 67. Rest of Asia-Pacific Codeine, by Distribution Channel USD Million (2016-2021)
  • Table 68. Europe Codeine, by Country USD Million (2016-2021)
  • Table 69. Europe Codeine, by Type USD Million (2016-2021)
  • Table 70. Europe Codeine, by Application USD Million (2016-2021)
  • Table 71. Europe Codeine, by Forms USD Million (2016-2021)
  • Table 72. Europe Codeine, by Distribution Channel USD Million (2016-2021)
  • Table 73. Germany Codeine, by Type USD Million (2016-2021)
  • Table 74. Germany Codeine, by Application USD Million (2016-2021)
  • Table 75. Germany Codeine, by Forms USD Million (2016-2021)
  • Table 76. Germany Codeine, by Distribution Channel USD Million (2016-2021)
  • Table 77. France Codeine, by Type USD Million (2016-2021)
  • Table 78. France Codeine, by Application USD Million (2016-2021)
  • Table 79. France Codeine, by Forms USD Million (2016-2021)
  • Table 80. France Codeine, by Distribution Channel USD Million (2016-2021)
  • Table 81. Italy Codeine, by Type USD Million (2016-2021)
  • Table 82. Italy Codeine, by Application USD Million (2016-2021)
  • Table 83. Italy Codeine, by Forms USD Million (2016-2021)
  • Table 84. Italy Codeine, by Distribution Channel USD Million (2016-2021)
  • Table 85. United Kingdom Codeine, by Type USD Million (2016-2021)
  • Table 86. United Kingdom Codeine, by Application USD Million (2016-2021)
  • Table 87. United Kingdom Codeine, by Forms USD Million (2016-2021)
  • Table 88. United Kingdom Codeine, by Distribution Channel USD Million (2016-2021)
  • Table 89. Netherlands Codeine, by Type USD Million (2016-2021)
  • Table 90. Netherlands Codeine, by Application USD Million (2016-2021)
  • Table 91. Netherlands Codeine, by Forms USD Million (2016-2021)
  • Table 92. Netherlands Codeine, by Distribution Channel USD Million (2016-2021)
  • Table 93. Rest of Europe Codeine, by Type USD Million (2016-2021)
  • Table 94. Rest of Europe Codeine, by Application USD Million (2016-2021)
  • Table 95. Rest of Europe Codeine, by Forms USD Million (2016-2021)
  • Table 96. Rest of Europe Codeine, by Distribution Channel USD Million (2016-2021)
  • Table 97. MEA Codeine, by Country USD Million (2016-2021)
  • Table 98. MEA Codeine, by Type USD Million (2016-2021)
  • Table 99. MEA Codeine, by Application USD Million (2016-2021)
  • Table 100. MEA Codeine, by Forms USD Million (2016-2021)
  • Table 101. MEA Codeine, by Distribution Channel USD Million (2016-2021)
  • Table 102. Middle East Codeine, by Type USD Million (2016-2021)
  • Table 103. Middle East Codeine, by Application USD Million (2016-2021)
  • Table 104. Middle East Codeine, by Forms USD Million (2016-2021)
  • Table 105. Middle East Codeine, by Distribution Channel USD Million (2016-2021)
  • Table 106. Africa Codeine, by Type USD Million (2016-2021)
  • Table 107. Africa Codeine, by Application USD Million (2016-2021)
  • Table 108. Africa Codeine, by Forms USD Million (2016-2021)
  • Table 109. Africa Codeine, by Distribution Channel USD Million (2016-2021)
  • Table 110. North America Codeine, by Country USD Million (2016-2021)
  • Table 111. North America Codeine, by Type USD Million (2016-2021)
  • Table 112. North America Codeine, by Application USD Million (2016-2021)
  • Table 113. North America Codeine, by Forms USD Million (2016-2021)
  • Table 114. North America Codeine, by Distribution Channel USD Million (2016-2021)
  • Table 115. United States Codeine, by Type USD Million (2016-2021)
  • Table 116. United States Codeine, by Application USD Million (2016-2021)
  • Table 117. United States Codeine, by Forms USD Million (2016-2021)
  • Table 118. United States Codeine, by Distribution Channel USD Million (2016-2021)
  • Table 119. Canada Codeine, by Type USD Million (2016-2021)
  • Table 120. Canada Codeine, by Application USD Million (2016-2021)
  • Table 121. Canada Codeine, by Forms USD Million (2016-2021)
  • Table 122. Canada Codeine, by Distribution Channel USD Million (2016-2021)
  • Table 123. Mexico Codeine, by Type USD Million (2016-2021)
  • Table 124. Mexico Codeine, by Application USD Million (2016-2021)
  • Table 125. Mexico Codeine, by Forms USD Million (2016-2021)
  • Table 126. Mexico Codeine, by Distribution Channel USD Million (2016-2021)
  • Table 127. Codeine Sales: by Type(K Units)
  • Table 128. Codeine Sales Extracted from Opium , by Region K Units (2016-2021)
  • Table 129. Codeine Sales Synthesized by Morphine , by Region K Units (2016-2021)
  • Table 130. Codeine Sales: by Application(K Units)
  • Table 131. Codeine Sales Pain Management , by Region K Units (2016-2021)
  • Table 132. Codeine Sales Cough Treatment , by Region K Units (2016-2021)
  • Table 133. Codeine Sales Diarrhea Treatment , by Region K Units (2016-2021)
  • Table 134. Codeine Sales: by Forms(K Units)
  • Table 135. Codeine Sales Tablets , by Region K Units (2016-2021)
  • Table 136. Codeine Sales Capsules , by Region K Units (2016-2021)
  • Table 137. Codeine Sales Suppositories , by Region K Units (2016-2021)
  • Table 138. Codeine Sales Soluble Powders and Tablets , by Region K Units (2016-2021)
  • Table 139. Codeine Sales Liquids , by Region K Units (2016-2021)
  • Table 140. Codeine Sales: by Distribution Channel(K Units)
  • Table 141. Codeine Sales Hospital Pharmacies , by Region K Units (2016-2021)
  • Table 142. Codeine Sales Retail Pharmacies , by Region K Units (2016-2021)
  • Table 143. Codeine Sales Others , by Region K Units (2016-2021)
  • Table 144. South America Codeine Sales, by Country K Units (2016-2021)
  • Table 145. South America Codeine Sales, by Type K Units (2016-2021)
  • Table 146. South America Codeine Sales, by Application K Units (2016-2021)
  • Table 147. South America Codeine Sales, by Forms K Units (2016-2021)
  • Table 148. South America Codeine Sales, by Distribution Channel K Units (2016-2021)
  • Table 149. Brazil Codeine Sales, by Type K Units (2016-2021)
  • Table 150. Brazil Codeine Sales, by Application K Units (2016-2021)
  • Table 151. Brazil Codeine Sales, by Forms K Units (2016-2021)
  • Table 152. Brazil Codeine Sales, by Distribution Channel K Units (2016-2021)
  • Table 153. Argentina Codeine Sales, by Type K Units (2016-2021)
  • Table 154. Argentina Codeine Sales, by Application K Units (2016-2021)
  • Table 155. Argentina Codeine Sales, by Forms K Units (2016-2021)
  • Table 156. Argentina Codeine Sales, by Distribution Channel K Units (2016-2021)
  • Table 157. Rest of South America Codeine Sales, by Type K Units (2016-2021)
  • Table 158. Rest of South America Codeine Sales, by Application K Units (2016-2021)
  • Table 159. Rest of South America Codeine Sales, by Forms K Units (2016-2021)
  • Table 160. Rest of South America Codeine Sales, by Distribution Channel K Units (2016-2021)
  • Table 161. Asia Pacific Codeine Sales, by Country K Units (2016-2021)
  • Table 162. Asia Pacific Codeine Sales, by Type K Units (2016-2021)
  • Table 163. Asia Pacific Codeine Sales, by Application K Units (2016-2021)
  • Table 164. Asia Pacific Codeine Sales, by Forms K Units (2016-2021)
  • Table 165. Asia Pacific Codeine Sales, by Distribution Channel K Units (2016-2021)
  • Table 166. China Codeine Sales, by Type K Units (2016-2021)
  • Table 167. China Codeine Sales, by Application K Units (2016-2021)
  • Table 168. China Codeine Sales, by Forms K Units (2016-2021)
  • Table 169. China Codeine Sales, by Distribution Channel K Units (2016-2021)
  • Table 170. Japan Codeine Sales, by Type K Units (2016-2021)
  • Table 171. Japan Codeine Sales, by Application K Units (2016-2021)
  • Table 172. Japan Codeine Sales, by Forms K Units (2016-2021)
  • Table 173. Japan Codeine Sales, by Distribution Channel K Units (2016-2021)
  • Table 174. India Codeine Sales, by Type K Units (2016-2021)
  • Table 175. India Codeine Sales, by Application K Units (2016-2021)
  • Table 176. India Codeine Sales, by Forms K Units (2016-2021)
  • Table 177. India Codeine Sales, by Distribution Channel K Units (2016-2021)
  • Table 178. South Korea Codeine Sales, by Type K Units (2016-2021)
  • Table 179. South Korea Codeine Sales, by Application K Units (2016-2021)
  • Table 180. South Korea Codeine Sales, by Forms K Units (2016-2021)
  • Table 181. South Korea Codeine Sales, by Distribution Channel K Units (2016-2021)
  • Table 182. Taiwan Codeine Sales, by Type K Units (2016-2021)
  • Table 183. Taiwan Codeine Sales, by Application K Units (2016-2021)
  • Table 184. Taiwan Codeine Sales, by Forms K Units (2016-2021)
  • Table 185. Taiwan Codeine Sales, by Distribution Channel K Units (2016-2021)
  • Table 186. Australia Codeine Sales, by Type K Units (2016-2021)
  • Table 187. Australia Codeine Sales, by Application K Units (2016-2021)
  • Table 188. Australia Codeine Sales, by Forms K Units (2016-2021)
  • Table 189. Australia Codeine Sales, by Distribution Channel K Units (2016-2021)
  • Table 190. Rest of Asia-Pacific Codeine Sales, by Type K Units (2016-2021)
  • Table 191. Rest of Asia-Pacific Codeine Sales, by Application K Units (2016-2021)
  • Table 192. Rest of Asia-Pacific Codeine Sales, by Forms K Units (2016-2021)
  • Table 193. Rest of Asia-Pacific Codeine Sales, by Distribution Channel K Units (2016-2021)
  • Table 194. Europe Codeine Sales, by Country K Units (2016-2021)
  • Table 195. Europe Codeine Sales, by Type K Units (2016-2021)
  • Table 196. Europe Codeine Sales, by Application K Units (2016-2021)
  • Table 197. Europe Codeine Sales, by Forms K Units (2016-2021)
  • Table 198. Europe Codeine Sales, by Distribution Channel K Units (2016-2021)
  • Table 199. Germany Codeine Sales, by Type K Units (2016-2021)
  • Table 200. Germany Codeine Sales, by Application K Units (2016-2021)
  • Table 201. Germany Codeine Sales, by Forms K Units (2016-2021)
  • Table 202. Germany Codeine Sales, by Distribution Channel K Units (2016-2021)
  • Table 203. France Codeine Sales, by Type K Units (2016-2021)
  • Table 204. France Codeine Sales, by Application K Units (2016-2021)
  • Table 205. France Codeine Sales, by Forms K Units (2016-2021)
  • Table 206. France Codeine Sales, by Distribution Channel K Units (2016-2021)
  • Table 207. Italy Codeine Sales, by Type K Units (2016-2021)
  • Table 208. Italy Codeine Sales, by Application K Units (2016-2021)
  • Table 209. Italy Codeine Sales, by Forms K Units (2016-2021)
  • Table 210. Italy Codeine Sales, by Distribution Channel K Units (2016-2021)
  • Table 211. United Kingdom Codeine Sales, by Type K Units (2016-2021)
  • Table 212. United Kingdom Codeine Sales, by Application K Units (2016-2021)
  • Table 213. United Kingdom Codeine Sales, by Forms K Units (2016-2021)
  • Table 214. United Kingdom Codeine Sales, by Distribution Channel K Units (2016-2021)
  • Table 215. Netherlands Codeine Sales, by Type K Units (2016-2021)
  • Table 216. Netherlands Codeine Sales, by Application K Units (2016-2021)
  • Table 217. Netherlands Codeine Sales, by Forms K Units (2016-2021)
  • Table 218. Netherlands Codeine Sales, by Distribution Channel K Units (2016-2021)
  • Table 219. Rest of Europe Codeine Sales, by Type K Units (2016-2021)
  • Table 220. Rest of Europe Codeine Sales, by Application K Units (2016-2021)
  • Table 221. Rest of Europe Codeine Sales, by Forms K Units (2016-2021)
  • Table 222. Rest of Europe Codeine Sales, by Distribution Channel K Units (2016-2021)
  • Table 223. MEA Codeine Sales, by Country K Units (2016-2021)
  • Table 224. MEA Codeine Sales, by Type K Units (2016-2021)
  • Table 225. MEA Codeine Sales, by Application K Units (2016-2021)
  • Table 226. MEA Codeine Sales, by Forms K Units (2016-2021)
  • Table 227. MEA Codeine Sales, by Distribution Channel K Units (2016-2021)
  • Table 228. Middle East Codeine Sales, by Type K Units (2016-2021)
  • Table 229. Middle East Codeine Sales, by Application K Units (2016-2021)
  • Table 230. Middle East Codeine Sales, by Forms K Units (2016-2021)
  • Table 231. Middle East Codeine Sales, by Distribution Channel K Units (2016-2021)
  • Table 232. Africa Codeine Sales, by Type K Units (2016-2021)
  • Table 233. Africa Codeine Sales, by Application K Units (2016-2021)
  • Table 234. Africa Codeine Sales, by Forms K Units (2016-2021)
  • Table 235. Africa Codeine Sales, by Distribution Channel K Units (2016-2021)
  • Table 236. North America Codeine Sales, by Country K Units (2016-2021)
  • Table 237. North America Codeine Sales, by Type K Units (2016-2021)
  • Table 238. North America Codeine Sales, by Application K Units (2016-2021)
  • Table 239. North America Codeine Sales, by Forms K Units (2016-2021)
  • Table 240. North America Codeine Sales, by Distribution Channel K Units (2016-2021)
  • Table 241. United States Codeine Sales, by Type K Units (2016-2021)
  • Table 242. United States Codeine Sales, by Application K Units (2016-2021)
  • Table 243. United States Codeine Sales, by Forms K Units (2016-2021)
  • Table 244. United States Codeine Sales, by Distribution Channel K Units (2016-2021)
  • Table 245. Canada Codeine Sales, by Type K Units (2016-2021)
  • Table 246. Canada Codeine Sales, by Application K Units (2016-2021)
  • Table 247. Canada Codeine Sales, by Forms K Units (2016-2021)
  • Table 248. Canada Codeine Sales, by Distribution Channel K Units (2016-2021)
  • Table 249. Mexico Codeine Sales, by Type K Units (2016-2021)
  • Table 250. Mexico Codeine Sales, by Application K Units (2016-2021)
  • Table 251. Mexico Codeine Sales, by Forms K Units (2016-2021)
  • Table 252. Mexico Codeine Sales, by Distribution Channel K Units (2016-2021)
  • Table 253. Codeine: by Type(USD/Units)
  • Table 254. Company Basic Information, Sales Area and Its Competitors
  • Table 255. Company Basic Information, Sales Area and Its Competitors
  • Table 256. Company Basic Information, Sales Area and Its Competitors
  • Table 257. Company Basic Information, Sales Area and Its Competitors
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Company Basic Information, Sales Area and Its Competitors
  • Table 260. Company Basic Information, Sales Area and Its Competitors
  • Table 261. Company Basic Information, Sales Area and Its Competitors
  • Table 262. Company Basic Information, Sales Area and Its Competitors
  • Table 263. Codeine: by Type(USD Million)
  • Table 264. Codeine Extracted from Opium , by Region USD Million (2022-2027)
  • Table 265. Codeine Synthesized by Morphine , by Region USD Million (2022-2027)
  • Table 266. Codeine: by Application(USD Million)
  • Table 267. Codeine Pain Management , by Region USD Million (2022-2027)
  • Table 268. Codeine Cough Treatment , by Region USD Million (2022-2027)
  • Table 269. Codeine Diarrhea Treatment , by Region USD Million (2022-2027)
  • Table 270. Codeine: by Forms(USD Million)
  • Table 271. Codeine Tablets , by Region USD Million (2022-2027)
  • Table 272. Codeine Capsules , by Region USD Million (2022-2027)
  • Table 273. Codeine Suppositories , by Region USD Million (2022-2027)
  • Table 274. Codeine Soluble Powders and Tablets , by Region USD Million (2022-2027)
  • Table 275. Codeine Liquids , by Region USD Million (2022-2027)
  • Table 276. Codeine: by Distribution Channel(USD Million)
  • Table 277. Codeine Hospital Pharmacies , by Region USD Million (2022-2027)
  • Table 278. Codeine Retail Pharmacies , by Region USD Million (2022-2027)
  • Table 279. Codeine Others , by Region USD Million (2022-2027)
  • Table 280. South America Codeine, by Country USD Million (2022-2027)
  • Table 281. South America Codeine, by Type USD Million (2022-2027)
  • Table 282. South America Codeine, by Application USD Million (2022-2027)
  • Table 283. South America Codeine, by Forms USD Million (2022-2027)
  • Table 284. South America Codeine, by Distribution Channel USD Million (2022-2027)
  • Table 285. Brazil Codeine, by Type USD Million (2022-2027)
  • Table 286. Brazil Codeine, by Application USD Million (2022-2027)
  • Table 287. Brazil Codeine, by Forms USD Million (2022-2027)
  • Table 288. Brazil Codeine, by Distribution Channel USD Million (2022-2027)
  • Table 289. Argentina Codeine, by Type USD Million (2022-2027)
  • Table 290. Argentina Codeine, by Application USD Million (2022-2027)
  • Table 291. Argentina Codeine, by Forms USD Million (2022-2027)
  • Table 292. Argentina Codeine, by Distribution Channel USD Million (2022-2027)
  • Table 293. Rest of South America Codeine, by Type USD Million (2022-2027)
  • Table 294. Rest of South America Codeine, by Application USD Million (2022-2027)
  • Table 295. Rest of South America Codeine, by Forms USD Million (2022-2027)
  • Table 296. Rest of South America Codeine, by Distribution Channel USD Million (2022-2027)
  • Table 297. Asia Pacific Codeine, by Country USD Million (2022-2027)
  • Table 298. Asia Pacific Codeine, by Type USD Million (2022-2027)
  • Table 299. Asia Pacific Codeine, by Application USD Million (2022-2027)
  • Table 300. Asia Pacific Codeine, by Forms USD Million (2022-2027)
  • Table 301. Asia Pacific Codeine, by Distribution Channel USD Million (2022-2027)
  • Table 302. China Codeine, by Type USD Million (2022-2027)
  • Table 303. China Codeine, by Application USD Million (2022-2027)
  • Table 304. China Codeine, by Forms USD Million (2022-2027)
  • Table 305. China Codeine, by Distribution Channel USD Million (2022-2027)
  • Table 306. Japan Codeine, by Type USD Million (2022-2027)
  • Table 307. Japan Codeine, by Application USD Million (2022-2027)
  • Table 308. Japan Codeine, by Forms USD Million (2022-2027)
  • Table 309. Japan Codeine, by Distribution Channel USD Million (2022-2027)
  • Table 310. India Codeine, by Type USD Million (2022-2027)
  • Table 311. India Codeine, by Application USD Million (2022-2027)
  • Table 312. India Codeine, by Forms USD Million (2022-2027)
  • Table 313. India Codeine, by Distribution Channel USD Million (2022-2027)
  • Table 314. South Korea Codeine, by Type USD Million (2022-2027)
  • Table 315. South Korea Codeine, by Application USD Million (2022-2027)
  • Table 316. South Korea Codeine, by Forms USD Million (2022-2027)
  • Table 317. South Korea Codeine, by Distribution Channel USD Million (2022-2027)
  • Table 318. Taiwan Codeine, by Type USD Million (2022-2027)
  • Table 319. Taiwan Codeine, by Application USD Million (2022-2027)
  • Table 320. Taiwan Codeine, by Forms USD Million (2022-2027)
  • Table 321. Taiwan Codeine, by Distribution Channel USD Million (2022-2027)
  • Table 322. Australia Codeine, by Type USD Million (2022-2027)
  • Table 323. Australia Codeine, by Application USD Million (2022-2027)
  • Table 324. Australia Codeine, by Forms USD Million (2022-2027)
  • Table 325. Australia Codeine, by Distribution Channel USD Million (2022-2027)
  • Table 326. Rest of Asia-Pacific Codeine, by Type USD Million (2022-2027)
  • Table 327. Rest of Asia-Pacific Codeine, by Application USD Million (2022-2027)
  • Table 328. Rest of Asia-Pacific Codeine, by Forms USD Million (2022-2027)
  • Table 329. Rest of Asia-Pacific Codeine, by Distribution Channel USD Million (2022-2027)
  • Table 330. Europe Codeine, by Country USD Million (2022-2027)
  • Table 331. Europe Codeine, by Type USD Million (2022-2027)
  • Table 332. Europe Codeine, by Application USD Million (2022-2027)
  • Table 333. Europe Codeine, by Forms USD Million (2022-2027)
  • Table 334. Europe Codeine, by Distribution Channel USD Million (2022-2027)
  • Table 335. Germany Codeine, by Type USD Million (2022-2027)
  • Table 336. Germany Codeine, by Application USD Million (2022-2027)
  • Table 337. Germany Codeine, by Forms USD Million (2022-2027)
  • Table 338. Germany Codeine, by Distribution Channel USD Million (2022-2027)
  • Table 339. France Codeine, by Type USD Million (2022-2027)
  • Table 340. France Codeine, by Application USD Million (2022-2027)
  • Table 341. France Codeine, by Forms USD Million (2022-2027)
  • Table 342. France Codeine, by Distribution Channel USD Million (2022-2027)
  • Table 343. Italy Codeine, by Type USD Million (2022-2027)
  • Table 344. Italy Codeine, by Application USD Million (2022-2027)
  • Table 345. Italy Codeine, by Forms USD Million (2022-2027)
  • Table 346. Italy Codeine, by Distribution Channel USD Million (2022-2027)
  • Table 347. United Kingdom Codeine, by Type USD Million (2022-2027)
  • Table 348. United Kingdom Codeine, by Application USD Million (2022-2027)
  • Table 349. United Kingdom Codeine, by Forms USD Million (2022-2027)
  • Table 350. United Kingdom Codeine, by Distribution Channel USD Million (2022-2027)
  • Table 351. Netherlands Codeine, by Type USD Million (2022-2027)
  • Table 352. Netherlands Codeine, by Application USD Million (2022-2027)
  • Table 353. Netherlands Codeine, by Forms USD Million (2022-2027)
  • Table 354. Netherlands Codeine, by Distribution Channel USD Million (2022-2027)
  • Table 355. Rest of Europe Codeine, by Type USD Million (2022-2027)
  • Table 356. Rest of Europe Codeine, by Application USD Million (2022-2027)
  • Table 357. Rest of Europe Codeine, by Forms USD Million (2022-2027)
  • Table 358. Rest of Europe Codeine, by Distribution Channel USD Million (2022-2027)
  • Table 359. MEA Codeine, by Country USD Million (2022-2027)
  • Table 360. MEA Codeine, by Type USD Million (2022-2027)
  • Table 361. MEA Codeine, by Application USD Million (2022-2027)
  • Table 362. MEA Codeine, by Forms USD Million (2022-2027)
  • Table 363. MEA Codeine, by Distribution Channel USD Million (2022-2027)
  • Table 364. Middle East Codeine, by Type USD Million (2022-2027)
  • Table 365. Middle East Codeine, by Application USD Million (2022-2027)
  • Table 366. Middle East Codeine, by Forms USD Million (2022-2027)
  • Table 367. Middle East Codeine, by Distribution Channel USD Million (2022-2027)
  • Table 368. Africa Codeine, by Type USD Million (2022-2027)
  • Table 369. Africa Codeine, by Application USD Million (2022-2027)
  • Table 370. Africa Codeine, by Forms USD Million (2022-2027)
  • Table 371. Africa Codeine, by Distribution Channel USD Million (2022-2027)
  • Table 372. North America Codeine, by Country USD Million (2022-2027)
  • Table 373. North America Codeine, by Type USD Million (2022-2027)
  • Table 374. North America Codeine, by Application USD Million (2022-2027)
  • Table 375. North America Codeine, by Forms USD Million (2022-2027)
  • Table 376. North America Codeine, by Distribution Channel USD Million (2022-2027)
  • Table 377. United States Codeine, by Type USD Million (2022-2027)
  • Table 378. United States Codeine, by Application USD Million (2022-2027)
  • Table 379. United States Codeine, by Forms USD Million (2022-2027)
  • Table 380. United States Codeine, by Distribution Channel USD Million (2022-2027)
  • Table 381. Canada Codeine, by Type USD Million (2022-2027)
  • Table 382. Canada Codeine, by Application USD Million (2022-2027)
  • Table 383. Canada Codeine, by Forms USD Million (2022-2027)
  • Table 384. Canada Codeine, by Distribution Channel USD Million (2022-2027)
  • Table 385. Mexico Codeine, by Type USD Million (2022-2027)
  • Table 386. Mexico Codeine, by Application USD Million (2022-2027)
  • Table 387. Mexico Codeine, by Forms USD Million (2022-2027)
  • Table 388. Mexico Codeine, by Distribution Channel USD Million (2022-2027)
  • Table 389. Codeine Sales: by Type(K Units)
  • Table 390. Codeine Sales Extracted from Opium , by Region K Units (2022-2027)
  • Table 391. Codeine Sales Synthesized by Morphine , by Region K Units (2022-2027)
  • Table 392. Codeine Sales: by Application(K Units)
  • Table 393. Codeine Sales Pain Management , by Region K Units (2022-2027)
  • Table 394. Codeine Sales Cough Treatment , by Region K Units (2022-2027)
  • Table 395. Codeine Sales Diarrhea Treatment , by Region K Units (2022-2027)
  • Table 396. Codeine Sales: by Forms(K Units)
  • Table 397. Codeine Sales Tablets , by Region K Units (2022-2027)
  • Table 398. Codeine Sales Capsules , by Region K Units (2022-2027)
  • Table 399. Codeine Sales Suppositories , by Region K Units (2022-2027)
  • Table 400. Codeine Sales Soluble Powders and Tablets , by Region K Units (2022-2027)
  • Table 401. Codeine Sales Liquids , by Region K Units (2022-2027)
  • Table 402. Codeine Sales: by Distribution Channel(K Units)
  • Table 403. Codeine Sales Hospital Pharmacies , by Region K Units (2022-2027)
  • Table 404. Codeine Sales Retail Pharmacies , by Region K Units (2022-2027)
  • Table 405. Codeine Sales Others , by Region K Units (2022-2027)
  • Table 406. South America Codeine Sales, by Country K Units (2022-2027)
  • Table 407. South America Codeine Sales, by Type K Units (2022-2027)
  • Table 408. South America Codeine Sales, by Application K Units (2022-2027)
  • Table 409. South America Codeine Sales, by Forms K Units (2022-2027)
  • Table 410. South America Codeine Sales, by Distribution Channel K Units (2022-2027)
  • Table 411. Brazil Codeine Sales, by Type K Units (2022-2027)
  • Table 412. Brazil Codeine Sales, by Application K Units (2022-2027)
  • Table 413. Brazil Codeine Sales, by Forms K Units (2022-2027)
  • Table 414. Brazil Codeine Sales, by Distribution Channel K Units (2022-2027)
  • Table 415. Argentina Codeine Sales, by Type K Units (2022-2027)
  • Table 416. Argentina Codeine Sales, by Application K Units (2022-2027)
  • Table 417. Argentina Codeine Sales, by Forms K Units (2022-2027)
  • Table 418. Argentina Codeine Sales, by Distribution Channel K Units (2022-2027)
  • Table 419. Rest of South America Codeine Sales, by Type K Units (2022-2027)
  • Table 420. Rest of South America Codeine Sales, by Application K Units (2022-2027)
  • Table 421. Rest of South America Codeine Sales, by Forms K Units (2022-2027)
  • Table 422. Rest of South America Codeine Sales, by Distribution Channel K Units (2022-2027)
  • Table 423. Asia Pacific Codeine Sales, by Country K Units (2022-2027)
  • Table 424. Asia Pacific Codeine Sales, by Type K Units (2022-2027)
  • Table 425. Asia Pacific Codeine Sales, by Application K Units (2022-2027)
  • Table 426. Asia Pacific Codeine Sales, by Forms K Units (2022-2027)
  • Table 427. Asia Pacific Codeine Sales, by Distribution Channel K Units (2022-2027)
  • Table 428. China Codeine Sales, by Type K Units (2022-2027)
  • Table 429. China Codeine Sales, by Application K Units (2022-2027)
  • Table 430. China Codeine Sales, by Forms K Units (2022-2027)
  • Table 431. China Codeine Sales, by Distribution Channel K Units (2022-2027)
  • Table 432. Japan Codeine Sales, by Type K Units (2022-2027)
  • Table 433. Japan Codeine Sales, by Application K Units (2022-2027)
  • Table 434. Japan Codeine Sales, by Forms K Units (2022-2027)
  • Table 435. Japan Codeine Sales, by Distribution Channel K Units (2022-2027)
  • Table 436. India Codeine Sales, by Type K Units (2022-2027)
  • Table 437. India Codeine Sales, by Application K Units (2022-2027)
  • Table 438. India Codeine Sales, by Forms K Units (2022-2027)
  • Table 439. India Codeine Sales, by Distribution Channel K Units (2022-2027)
  • Table 440. South Korea Codeine Sales, by Type K Units (2022-2027)
  • Table 441. South Korea Codeine Sales, by Application K Units (2022-2027)
  • Table 442. South Korea Codeine Sales, by Forms K Units (2022-2027)
  • Table 443. South Korea Codeine Sales, by Distribution Channel K Units (2022-2027)
  • Table 444. Taiwan Codeine Sales, by Type K Units (2022-2027)
  • Table 445. Taiwan Codeine Sales, by Application K Units (2022-2027)
  • Table 446. Taiwan Codeine Sales, by Forms K Units (2022-2027)
  • Table 447. Taiwan Codeine Sales, by Distribution Channel K Units (2022-2027)
  • Table 448. Australia Codeine Sales, by Type K Units (2022-2027)
  • Table 449. Australia Codeine Sales, by Application K Units (2022-2027)
  • Table 450. Australia Codeine Sales, by Forms K Units (2022-2027)
  • Table 451. Australia Codeine Sales, by Distribution Channel K Units (2022-2027)
  • Table 452. Rest of Asia-Pacific Codeine Sales, by Type K Units (2022-2027)
  • Table 453. Rest of Asia-Pacific Codeine Sales, by Application K Units (2022-2027)
  • Table 454. Rest of Asia-Pacific Codeine Sales, by Forms K Units (2022-2027)
  • Table 455. Rest of Asia-Pacific Codeine Sales, by Distribution Channel K Units (2022-2027)
  • Table 456. Europe Codeine Sales, by Country K Units (2022-2027)
  • Table 457. Europe Codeine Sales, by Type K Units (2022-2027)
  • Table 458. Europe Codeine Sales, by Application K Units (2022-2027)
  • Table 459. Europe Codeine Sales, by Forms K Units (2022-2027)
  • Table 460. Europe Codeine Sales, by Distribution Channel K Units (2022-2027)
  • Table 461. Germany Codeine Sales, by Type K Units (2022-2027)
  • Table 462. Germany Codeine Sales, by Application K Units (2022-2027)
  • Table 463. Germany Codeine Sales, by Forms K Units (2022-2027)
  • Table 464. Germany Codeine Sales, by Distribution Channel K Units (2022-2027)
  • Table 465. France Codeine Sales, by Type K Units (2022-2027)
  • Table 466. France Codeine Sales, by Application K Units (2022-2027)
  • Table 467. France Codeine Sales, by Forms K Units (2022-2027)
  • Table 468. France Codeine Sales, by Distribution Channel K Units (2022-2027)
  • Table 469. Italy Codeine Sales, by Type K Units (2022-2027)
  • Table 470. Italy Codeine Sales, by Application K Units (2022-2027)
  • Table 471. Italy Codeine Sales, by Forms K Units (2022-2027)
  • Table 472. Italy Codeine Sales, by Distribution Channel K Units (2022-2027)
  • Table 473. United Kingdom Codeine Sales, by Type K Units (2022-2027)
  • Table 474. United Kingdom Codeine Sales, by Application K Units (2022-2027)
  • Table 475. United Kingdom Codeine Sales, by Forms K Units (2022-2027)
  • Table 476. United Kingdom Codeine Sales, by Distribution Channel K Units (2022-2027)
  • Table 477. Netherlands Codeine Sales, by Type K Units (2022-2027)
  • Table 478. Netherlands Codeine Sales, by Application K Units (2022-2027)
  • Table 479. Netherlands Codeine Sales, by Forms K Units (2022-2027)
  • Table 480. Netherlands Codeine Sales, by Distribution Channel K Units (2022-2027)
  • Table 481. Rest of Europe Codeine Sales, by Type K Units (2022-2027)
  • Table 482. Rest of Europe Codeine Sales, by Application K Units (2022-2027)
  • Table 483. Rest of Europe Codeine Sales, by Forms K Units (2022-2027)
  • Table 484. Rest of Europe Codeine Sales, by Distribution Channel K Units (2022-2027)
  • Table 485. MEA Codeine Sales, by Country K Units (2022-2027)
  • Table 486. MEA Codeine Sales, by Type K Units (2022-2027)
  • Table 487. MEA Codeine Sales, by Application K Units (2022-2027)
  • Table 488. MEA Codeine Sales, by Forms K Units (2022-2027)
  • Table 489. MEA Codeine Sales, by Distribution Channel K Units (2022-2027)
  • Table 490. Middle East Codeine Sales, by Type K Units (2022-2027)
  • Table 491. Middle East Codeine Sales, by Application K Units (2022-2027)
  • Table 492. Middle East Codeine Sales, by Forms K Units (2022-2027)
  • Table 493. Middle East Codeine Sales, by Distribution Channel K Units (2022-2027)
  • Table 494. Africa Codeine Sales, by Type K Units (2022-2027)
  • Table 495. Africa Codeine Sales, by Application K Units (2022-2027)
  • Table 496. Africa Codeine Sales, by Forms K Units (2022-2027)
  • Table 497. Africa Codeine Sales, by Distribution Channel K Units (2022-2027)
  • Table 498. North America Codeine Sales, by Country K Units (2022-2027)
  • Table 499. North America Codeine Sales, by Type K Units (2022-2027)
  • Table 500. North America Codeine Sales, by Application K Units (2022-2027)
  • Table 501. North America Codeine Sales, by Forms K Units (2022-2027)
  • Table 502. North America Codeine Sales, by Distribution Channel K Units (2022-2027)
  • Table 503. United States Codeine Sales, by Type K Units (2022-2027)
  • Table 504. United States Codeine Sales, by Application K Units (2022-2027)
  • Table 505. United States Codeine Sales, by Forms K Units (2022-2027)
  • Table 506. United States Codeine Sales, by Distribution Channel K Units (2022-2027)
  • Table 507. Canada Codeine Sales, by Type K Units (2022-2027)
  • Table 508. Canada Codeine Sales, by Application K Units (2022-2027)
  • Table 509. Canada Codeine Sales, by Forms K Units (2022-2027)
  • Table 510. Canada Codeine Sales, by Distribution Channel K Units (2022-2027)
  • Table 511. Mexico Codeine Sales, by Type K Units (2022-2027)
  • Table 512. Mexico Codeine Sales, by Application K Units (2022-2027)
  • Table 513. Mexico Codeine Sales, by Forms K Units (2022-2027)
  • Table 514. Mexico Codeine Sales, by Distribution Channel K Units (2022-2027)
  • Table 515. Codeine: by Type(USD/Units)
  • Table 516. Research Programs/Design for This Report
  • Table 517. Key Data Information from Secondary Sources
  • Table 518. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Codeine: by Type USD Million (2016-2021)
  • Figure 5. Global Codeine: by Application USD Million (2016-2021)
  • Figure 6. Global Codeine: by Forms USD Million (2016-2021)
  • Figure 7. Global Codeine: by Distribution Channel USD Million (2016-2021)
  • Figure 8. South America Codeine Share (%), by Country
  • Figure 9. Asia Pacific Codeine Share (%), by Country
  • Figure 10. Europe Codeine Share (%), by Country
  • Figure 11. MEA Codeine Share (%), by Country
  • Figure 12. North America Codeine Share (%), by Country
  • Figure 13. Global Codeine: by Type K Units (2016-2021)
  • Figure 14. Global Codeine: by Application K Units (2016-2021)
  • Figure 15. Global Codeine: by Forms K Units (2016-2021)
  • Figure 16. Global Codeine: by Distribution Channel K Units (2016-2021)
  • Figure 17. South America Codeine Share (%), by Country
  • Figure 18. Asia Pacific Codeine Share (%), by Country
  • Figure 19. Europe Codeine Share (%), by Country
  • Figure 20. MEA Codeine Share (%), by Country
  • Figure 21. North America Codeine Share (%), by Country
  • Figure 22. Global Codeine: by Type USD/Units (2016-2021)
  • Figure 23. Global Codeine share by Players 2021 (%)
  • Figure 24. Global Codeine share by Players (Top 3) 2021(%)
  • Figure 25. Global Codeine share by Players (Top 5) 2021(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. Purdue Pharma (United States) Revenue, Net Income and Gross profit
  • Figure 28. Purdue Pharma (United States) Revenue: by Geography 2021
  • Figure 29. Sanofi (France) Revenue, Net Income and Gross profit
  • Figure 30. Sanofi (France) Revenue: by Geography 2021
  • Figure 31. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 32. Pfizer (United States) Revenue: by Geography 2021
  • Figure 33. Janssen Pharmaceuticals (Belgium) Revenue, Net Income and Gross profit
  • Figure 34. Janssen Pharmaceuticals (Belgium) Revenue: by Geography 2021
  • Figure 35. Endo Pharmaceuticals, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 36. Endo Pharmaceuticals, Inc (United States) Revenue: by Geography 2021
  • Figure 37. Actavis Plc (United States) Revenue, Net Income and Gross profit
  • Figure 38. Actavis Plc (United States) Revenue: by Geography 2021
  • Figure 39. Egalet (United States) Revenue, Net Income and Gross profit
  • Figure 40. Egalet (United States) Revenue: by Geography 2021
  • Figure 41. Sun Pharmaceuticals (India) Revenue, Net Income and Gross profit
  • Figure 42. Sun Pharmaceuticals (India) Revenue: by Geography 2021
  • Figure 43. Boehringer Ingelheim GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 44. Boehringer Ingelheim GmbH (Germany) Revenue: by Geography 2021
  • Figure 45. Global Codeine: by Type USD Million (2022-2027)
  • Figure 46. Global Codeine: by Application USD Million (2022-2027)
  • Figure 47. Global Codeine: by Forms USD Million (2022-2027)
  • Figure 48. Global Codeine: by Distribution Channel USD Million (2022-2027)
  • Figure 49. South America Codeine Share (%), by Country
  • Figure 50. Asia Pacific Codeine Share (%), by Country
  • Figure 51. Europe Codeine Share (%), by Country
  • Figure 52. MEA Codeine Share (%), by Country
  • Figure 53. North America Codeine Share (%), by Country
  • Figure 54. Global Codeine: by Type K Units (2022-2027)
  • Figure 55. Global Codeine: by Application K Units (2022-2027)
  • Figure 56. Global Codeine: by Forms K Units (2022-2027)
  • Figure 57. Global Codeine: by Distribution Channel K Units (2022-2027)
  • Figure 58. South America Codeine Share (%), by Country
  • Figure 59. Asia Pacific Codeine Share (%), by Country
  • Figure 60. Europe Codeine Share (%), by Country
  • Figure 61. MEA Codeine Share (%), by Country
  • Figure 62. North America Codeine Share (%), by Country
  • Figure 63. Global Codeine: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Purdue Pharma (United States)
  • Sanofi (France)
  • Pfizer (United States)
  • Janssen Pharmaceuticals (Belgium)
  • Endo Pharmaceuticals, Inc (United States)
  • Actavis Plc (United States)
  • Egalet (United States)
  • Sun Pharmaceuticals (India)
  • Boehringer Ingelheim GmbH (Germany)
Select User Access Type

Key Highlights of Report


Sep 2021 246 Pages 70 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Codeine Quantitative research analysis
Global Codeine Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Codeine market are Purdue Pharma (United States), Sanofi (France), Pfizer (United States), Janssen Pharmaceuticals (Belgium), Endo Pharmaceuticals, Inc (United States), Actavis Plc (United States), Egalet (United States), Sun Pharmaceuticals (India) and Boehringer Ingelheim GmbH (Germany), to name a few.
North America is dominating the Codeine Market.
"The Stringent Government Regulation Associated with Codeine" is seen as one of the major challenges by many Industry Players of Codeine Market
The Codeine market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get complete companies available in our research coverage.
The Codeine market is expected to see a steady growth rate during projected year 2021 to 2027.

Know More About Global Codeine Report?

Have a Query? Click Here

Other Related Reports

Pharmaceutical Excipients Comprehensive Study by Type (Inorganic Chemicals {Calcium Phosphates, Calcium Carbonate, Calcium Sulfate, Halites and Metallic Oxides}, Organic Chemicals {Carbohydrates (Sug...
$ 3750
Hyperimmune Globulins Comprehensive Study by Type (Hepatitis B Immunoglobulins, Rabies Immunoglobulins, Tetanus Immunoglobulins, Others), Application (Government Institutions, Private Sector, Others)...
$ 3650
Immunoglobulin Products Comprehensive Study by Type (IgA, IgG, IgM, IgD, IgE), Application (Chronic Inflammatory Demyelinating Polyneuropathy, Guillain-Barre Syndrome, Hypogammaglobulinemia, Immunode...
$ 3750
Hyperphosphatemia Drugs Comprehensive Study by Type (Aluminum Phosphate Binder, Iron Phosphate Binder, Magnesium Phosphate Binder, Calcium Phosphate Binder), Application (Hospitals, Clinics, Others),...
$ 3650
Cancer CDK Inhibitors Comprehensive Study by Type (Ibrance (palbociclib), Kisqali (ribociclib), Verzenio (abemaciclib)), Application (Hospitals, Clinics, Other), Distribution Channel (Hospital Pharma...
$ 3350
Human Chorionic Gonadotropin Comprehensive Study by Technology (Natural Source Extraction, Recombinant Technology), End User (Fertility Clinics, Research Institutions, Others), Therapeutic Area (Fema...
$ 3450